Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darolutamide as PSMA Enhancer in Localized Prostate Cancer
NCT05900973Phase 2Unknown
- Sponsor
- Instituto D’Or de Pesquisa e Ensino
- Start
- Jul 2023
- Primary completion
- May 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of darolutamide, sponsored by Instituto D’Or de Pesquisa e Ensino. Status: unknown.
02
Drugs
darolutamide
Beyond the preview
Go deeper on NCT05900973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05900973.